| |
Plasma protein level (ng/mL)
|
ANOVA test (pvalue)
|
|---|
|
ASt (n = 71)
|
nASt (n = 65)
|
NC (n = 40)
|
FP
|
ASt/nASt
|
ASt/NC
|
nASt/NC
|
|---|
|
SAA1
|
12.755 ± 6.990
|
9.468 ± 6.965
|
6.790 ± 4.529
|
5.645
|
.035
|
.002
|
.150
|
| | | | |
.005
| | | |
|
PIGR
|
37.868 ± 14.336
|
45.298 ± 14.325
|
60.734 ± 11.913
|
13.249
|
.038
|
.000
|
.001
|
| | | | |
.000
| | | |
|
ORM1
|
19.400 ± 5.557
|
22.217 ± 5.279
|
20.234 ± 2.940
|
2.309
|
.037
|
.589
|
.206
|
| | | | |
.106
| | | |
|
ZNF452
|
0.758 ± 0.362
|
0.701 ± 0.538
|
1.698 ± 1.112
|
16.84
|
.724
|
.004
|
.003
|
| | | | |
.000
| | | |
|
SPP24
|
2270.987 ± 304.153
|
2090.084 ± 264.598
|
1792.224 ± 266.44
|
15.057
|
.018
|
.000
|
.001
|
| | | | |
.000
| | | |
|
FASN
|
0.847 ± 0.275
|
1.129 ± 0.654
|
2.501 ± 1.114
|
34.913
|
.015
|
.000
|
.000
|
| | | | |
.000
| | | |
|
LBP
|
204.220 ± 24.523
|
199.499 ± 46.947
|
11.609 ± 4.454
|
146.833
|
.624
|
.000
|
.000
|
| | | | |
.000
| | | |
|
HYAL1
|
12.666 ± 5.069
|
11.785 ± 5.225
|
11.351 ± 5.330
|
4.71
|
.486
|
.368
|
.769
|
| | | | |
.626
| | | |
|
THBS1
|
4.154 ± 2.641
|
3.366 ± 1.922
|
1.579 ± 1.100
|
7.777
|
.148
|
.000
|
.008
|
| | | | |
.001
| | | |
- ASt, nASt or NC, refer to patients with Abnormal Savda type tumours, non-Abnormal Savda type tumours, or normal controls, respectively; ASt/nASt, ASt/NC, nASt/NC, comparative analysis between two groups indicated, with statistical significance at p< 0.05.
